Mission

Our mission is to make some of the rarest materials on Earth: the isotopes that medicine, industry, and ultimately, fusion power cannot live without.

StandardX is a UK-headquartered deep-tech company, building sovereign isotope supply for Britain and Europe at a moment when supply chain resilience has never mattered more. An isotope refinery replacing today's fragmented, single-product infrastructure.

Produced to order from a single compact platform, turning chronic scarcity into abundance, starting with the materials behind cancer care.

Who we are

A team that combines frontier research and 21st century industrial excellence

Founding Team

Dr Richard Pearson
CEO & Co-founder

Second-time founder (formerly Kyoto Fusioneering). PhD in fusion engineering with expertise in tritium supply and commercialisation. Combines scientific grounding with hands-on venture experience, and an established standing in the global fusion and nuclear ecosystem.

Dr Ross Allen
CTO & Co-founder

PhD in nuclear physics and third-time start-up operator. Specialist in accelerator-driven isotope production, and the architect of the StandardX platform. Brings rare combination of deep physics intuition with engineering and operational experience of building and scaling hard technology.

Team

Jeff Peachman
Lead Engineer

Brings a rare mechanical engineering depth and execution discipline built over 12 years at SpaceX, working on Falcon 9 and Starlink. Leads our engineering programme from concept through to operation.

Dr Carol Johnston
Accelerator Physics

40 years as a global leader designing, building and operating particle accelerators as a Senior Fermilab physicist. A pioneer of the FFA accelerator architecture driving physics innovation at StandardX.

Dr Sophie Morrison
Regulatory Lead

PhD from the University of Cambridge. 18 years in nuclear engineering, licensing and radiation safety. Leads our regulatory strategy and licensing programme.

Dr Grace Colverd
ML Lead

PhD in machine learning from the University of Cambridge. Leading AI/ML modelling, simulation tooling and digital twin infrastructure that sit at the heart of our accelerator design and system optimisation.

Mark Bray-Parry
Medical Partnerships

15 years across medical physics and business development in the nuclear medicine sector, including leading the UK's first clinical targeted alpha therapy trial. Leads engagement and partnerships across the radiopharma ecosystem.

Fadi Al-Zir
EC&I Lead

Former Principal Engineer at the UK Atomic Energy Authority. Expertise in the control and instrumentation of complex engineered systems, now applying it to accelerator operations.

Ian Pebody
Senior Target Engineer

Award-winning master's research at the University of Oxford. Leading the design of high-heat-flux targets for our high current system for isotope production.